El interés en corto de SG Holdings Co da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de SG Holdings Co. Los datos de interés en corto se actualizan cada dos semanas.

SG Holdings Co (OTC:SGHHF) Bolsa, Informe de interés en corto

SG Holdings Co Ltd along with its subsidiaries provides logistics-oriented one-stop solutions. The company is also engaged in Real estate to make effective use of real estate and facilities infrastructure centering on logistics, Automobile business in order to manufacture eco-specification vehicles, Human resource business to improve operations and improve service quality by sorting work at delivery bases, and it is also engaged in other business such as finance, IT, and human resource development.

SG Holdings Co Ltd

Hannover Rueck (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HVRRY#OTC">HVRRY</a>) reported quarterly earnings of $2.09 per share. This is a 16.73 percent decrease over earnings of $2.51 per share from the same period last year. The company reported $7.33 billion in sales this quarter. This is a 1.13 percent increase over sales of $7.25 billion the same period last year.

Earnings

News

Hannover Ruckversicherungs Registered shares 

HVRRY

Hannover Rueck Q1 EPS $2.09 Down From $2.51 YoY, Sales $7.33B Up From $7.25B YoY

WIIM

LOBO

LOBO EV Technologies shares are trading higher after the company issued a year-over-year increase in its FY25 revenue guidance.

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Agenus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGEN#NASDAQ">AGEN</a>) from Neutral to Neutral.

Reiteration

Analyst Ratings

AGEN

HC Wainwright & Co. Reiterates Neutral on Agenusto Neutral

- BMB-101 demonstrated a complete elimination of drop attacks in the DBA/2 mouse model -
- The DBA/2 model is highly predictive of sudden unexpected death in epilepsy (SUDEP) -
- Findings highlight BMB-101's potential to address critical gaps in SUDEP prevention -
NEW YORK and VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/DRUG#CSE">DRUG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRUG#NASDAQ">DRUG</a>) ("Bright Minds" or the "Company"), a company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders, today announced positive findings from its DBA/2 mouse model study. BMB-101, the Company's novel scaffold 5-HT2C Gq-protein biased agonist, demonstrated a complete elimination of drop attacks in the DBA/2 mouse model.

Biotech

General

CSE:DRUG

DRUG

Bright Minds Biosciences Announces Findings From Its DBA/2 Mouse Model Study Evaluating BMB-101; Demonstrated A Complete Elimination Of Drop Attacks; Findings Highlight BMB-101's Potential To Address Critical Gaps In SUDEP Prevention

ARCT

Arcturus Therapeutics shares are trading higher after the company reported Q1 financial results and beat its EPS and revenue estimates.

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/05/12/final-trades-citigroup-truist-financial-and-amazon.html">Halftime Report Final Trades</a>,&#8221; Jim Lebenthal of Cerity Partners named Citigroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), a <a href="https://www.benzinga.com/quote/C/analyst-ratings">financial stock, as his final trade.</a>
Supporting his view, Oppenheimer analyst Chris Kotowski, on April 28, maintained Citigroup with an Outperform rating and raised the price target from $91 to $94.
Stephanie Link, chief investment strategist and portfolio manager at Hightower, said Truist Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) has a 5% dividend yield.
Lending support to her choice, Truist Finl, on April 17, reported quarterly earnings of 87 cents per share which met the analyst consensus estimate. The company reported quarterly sales of $4.947 billion which beat the analyst consensus estimate of $4.937 billion.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Joseph M. Terranova, Senior Managing Director for Virtus Investment Partners, picked Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) as his final trade.
Shares of Amazon.com rose sharply on Monday after the U.S. and China announced a temporary easing of tariffs, marking a significant step toward de-escalating long-standing trade tensions. The move lifted investor sentiment across sectors and boosted shares of companies heavily reliant on global supply chains.
Price Action:
<ul class="wp-block-list">
<li>Citi shares gained 4.8% to close at $74.91 on Monday.</li>
<li>Truist Financial shares rose 5.4% to settle at $41.12 during Monday's session.</li>
<li>Amazon shares jumped 8.1% to close at $208.64 on Monday.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/05/45347009/top-2-tech-stocks-that-may-crash-in-q2">Top 2 Tech Stocks That May Crash In Q2</a></li>
</ul>
Image: Shutterstock

Analyst Color

AMZN

Citigroup, Truist Financial And A Consumer Cyclical Stock On CNBC's 'Final Trades'

Barrington Research analyst Vincent Colicchio maintains Climb Global Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMB#NASDAQ">CLMB</a>) with a Outperform and maintains $136 price target.

Price Target

CLMB

Barrington Research Maintains Outperform on Climb Global Solutions, Maintains $136 Price Target

RGNX

Regenxbio shares are trading higher following Q1 financial results and after the company announced FDA acceptance and priority review of BLA for RGX-121.

Trio-Tech Intl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TRT#AMEX">TRT</a>) reported quarterly losses of $(0.12) per share. This is a 700 percent decrease over earnings of $0.02 per share from the same period last year. The company reported $7.38 million in sales this quarter. This is a 28.99 percent decrease over sales of $10.40 million the same period last year.

Trio-Tech Intl Q3 EPS $(0.12) Down From $0.02 YoY, Sales $7.38M Down From $10.40M YoY

Earnings Misses

MREO

CORRECTION: Mereo BioPharma Q1 GAAP EPS $(0.02) Misses $(0.01) Estimate. Cash And Equivalents Of $62.5M

Oblong (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBLG#NASDAQ">OBLG</a>) reported quarterly losses of $(0.59) per share. This is a 70.79 percent increase over losses of $(2.02) per share from the same period last year. The company reported $622.00 thousand in sales this quarter. This is a 0.64 percent decrease over sales of $626.00 thousand the same period last year.

OBLG

Oblong Q1 EPS $(0.59) Up From $(2.02) YoY, Sales $622.00K Down From $626.00K YoY

Barrington Research analyst Gary Prestopino maintains Koppers Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KOP#NYSE">KOP</a>) with a Outperform and maintains $64 price target.

Barrington Research Maintains Outperform on Koppers Holdings, Maintains $64 Price Target

Trading Halt: Halted at 8:40:00 a.m. ET - Trading Halt: Halt News Pending

RDE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIFT#NASDAQ">GIFT</a>) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 15.38 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $22.28 million which missed the analyst consensus estimate of $24.80 million by 10.17 percent. This is a 3.51 percent increase over sales of $21.52 million the same period last year.

Earnings Beats

GIFT

RDE Q1 EPS $(0.11) Beats $(0.12) Estimate, Sales $22.28M Miss $24.80M Estimate

Venture Global shares are trading lower after the company reported a Q1 EPS miss.

Government

Regulations

CWCO

Consolidated Water Subsidiary Receives Approval From Honolulu Board of Water Supply For Its Seawater Desalination Plant Project in Hawaii

BTC Digital Ltd. ("BTCT" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCT#NASDAQ">BTCT</a>), a blockchain technology company, today announced a significant expansion of its proprietary mining operations with the deployment of 400 new Bitmain Antminer T21 machines, adding approximately 76 PH/s of&nbsp;Bitcoin mining hash rate. In parallel, the Company has also introduced 24 Bitmain Antminer L9 machines to its operations, contributing an additional 380 GH/s of Litecoin (LTC) mining capacity.
This latest deployment of 400 Antminer T21 units (the "T21 miner") underscores BTCT's commitment to enhancing its Bitcoin mining capabilities. Each T21 miner delivers up to 190 TH/s and features an advanced air-cooling system designed for efficient heat dissipation and stable operation.
In addition to bolstering Bitcoin mining, BTCT is also expanding into Litecoin (the "LTC") mining with the installation of 24 Antminer L9 units (the "L9 miner"). Each L9 miner provides approximately 16 GH/s and supports the Scrypt algorithm, making it suitable for mining LTC, DOGE, and other similar cryptocurrencies. The Company intends to further scale its LTC mining operations in the near future.

BTCT

BTC Digital Expands Proprietary Mining Operations With Deployment Of 400 New Bitmain Antminer T21 Machines, Adding About 76 PH/s Of Bitcoin Mining Hash Rate

Full Year 2025 Outlook - Revised
"Strong demand and operational execution in the first quarter resulted in operating cash flow of $28.4 million. Operating cash flow net of capital expenditures of $1.8 million, which is less than 2% of sales, highlights the cash generation capabilities of our portfolio," stated Glenn D'Alessandro, Loar Treasurer and CFO. "As we look to the balance of the year, we expect the current demand environment to continue and have revised our guidance upward as a result."
<ul>
<li>Net sales - between $482 million and $490 million, up from between $480 million and $488 million.</li>
<li>Net income - between $59.0 million and $64.0 million, up from between $58 million and $63 million.</li>
<li>Adjusted EBITDA - between $182 million and $185 million, up from between $180 million and $184 million.</li>
<li>Diluted Earnings per share - between $0.61 and $0.66, up from between $0.60 and $0.65.</li>
<li>Net income margin - approximately 12%.</li>
<li>Adjusted Earnings Per Share -between $0.71 and $0.76 up from between $0.70 and $0.75.</li>
<li>Adjusted EBITDA Margin - approximately 37.5%.</li>
<li>Interest expense - approximately $28 million.</li>
<li>Market Assumptions - Full year outlook is based on the following assumptions:</li>
<li>Commercial, Business Jet, and General Aviation OEM growth of high single-digits.</li>
<li>Commercial, Business Jet, and General Aviation aftermarket growth of low double-digits.</li>
<li>Defense growth of high double-digits.</li>
</ul>

Guidance

LOAR

Loar Holdings Raises FY2025 Adj EPS Guidance from $0.70-$0.75 to $0.71-$0.76 vs $0.69 Est; Raises Sales Guidance from $480M-$488M to $482M-$490M vs $490.48M Est

ACCESS Newswire (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ACCS#AMEX">ACCS</a>) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.13 by 61.54 percent. This is a 150 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $5.48 million which missed the analyst consensus estimate of $5.92 million by 7.42 percent. This is a 1.72 percent decrease over sales of $5.57 million the same period last year.

Comments

SG Holdings Co

Interés en corto

SG Holdings Co (OTC:SGHHF) Bolsa, Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL